Crossref


1. Immune-related biochemical markers and 20-year incidence of atherosclerotic cardiovascular disease: the ATTICA study (2002–2022)

- Sofia-Panagiota Giannakopoulou

- Christina Chrysohoou

- Smaragdi Antonopoulou

- Fotios Barkas

- Nikos Vlachogiannis

- Evrydiki Kravvariti

- Evangelos Liberopoulos

- Christos Pitsavos

- Costas Tsioufis

- Demosthenes Panagiotakos

- Petros P. Sfikakis

2. Long-term prognostic value of apolipoprotein Β levels in patients with very premature (≤40 years) acute coronary syndrome

- Loukianos S. Rallidis

- Sofia-Panagiota Giannakopoulou

- Stylianos Armylagos

- Christos Kotakos

- Stylianos L. Rallidis

- Eleni P. Stathopoulou

- Demosthenes Panagiotakos

3. An Overview of the Treatment Options Used for the Management of COVID-19 in Pakistan: Retrospective Observational Study

- Hashaam Akhtar

- Samar Akhtar

- Fazal-Ul Rahman

- Maham Afridi

- Sundas Khalid

- Sabahat Ali

- Nasim Akhtar

- Yousef S Khader

- Hamaad Ahmad

- Muhammad Mujeeb Khan

4. Improvement in the Prediction of Cerebrovascular Events With White Matter Hyperintensity

- Adam de Havenon

- Eric E. Smith

- Richa Sharma

- Guido J. Falcone

- Aaron Bangad

- Shyam Prabhakaran

- Kevin N. Sheth

5. Prognostic Interplay of Functional Status and Multimorbidity Among Older Patients Discharged From Hospital

- Andrea Corsonello

- Luca Soraci

- Mirko Di Rosa

- Silvia Bustacchini

- Anna Rita Bonfigli

- Rosamaria Lisa

- Rosa Liperoti

- Mauro Tettamanti

- Antonio Cherubini

- Roberto Antonicelli

- Giuseppe Pelliccioni

- Demetrio Postacchini

- Fabrizia Lattanzio

7. Optimizing gestational diabetes diagnostic criteria to predict adverse perinatal outcomes in the United Arab Emirates: The Mutaba’ah Study

- Maryam M. Bashir

- Luai A. Ahmed

- Rami H. Al-Rifai

- Iffat Elbarazi

- Tom Loney

- Bachar Afandi

- Juma M. Alkaabi

- Fatma Al-Maskari

8. Escala APACHE II para pacientes críticos con cáncer sólido. Estudio de reclasificación

- F.D. Martos-Benítez

- I. Cordero-Escobar

- A. Soto-García

- I. Betancourt-Plaza

- I. González-Martínez

9. Comparative analysis of obesity indices in discrimination and reclassification of cardiovascular disease risk: The ATTICA study (2002–2022)

- Sofia-Panagiota Giannakopoulou

- Fotios Barkas

- Christina Chrysohoou

- Evangelos Liberopoulos

- Petros P. Sfikakis

- Christos Pitsavos

- Costas Tsioufis

- Demosthenes Panagiotakos

10. APACHE II score for critically ill patients with a solid tumor: A reclassification study

- F.D. Martos-Benítez

- I. Cordero-Escobar

- A. Soto-García

- I. Betancourt-Plaza

- I. González-Martínez

11. Discrimination and net-reclassification of cardiovascular disease risk with lipoprotein(a) levels: The ATTICA study (2002–2022)

- Sofia-Panagiota Giannakopoulou

- Christina Chrysohoou

- Smaragdi Antonopoulou

- Evangelia Damigou

- Fotios Barkas

- Christina Vafia

- Evrydiki Kravvariti

- Costas Tsioufis

- Christos Pitsavos

- Evangelos Liberopoulos

- Petros P. Sfikakis

- Demosthenes Panagiotakos

12. Blood levels of immune-related biomarkers and future risk for prefrailty/frailty: The prospective ATTICA sub-study 2002–2024

- Sofia-Panagiota Giannakopoulou

- Danai Sgouropoulou

- Fotios Barkas

- Evangelos Liberopoulos

- Christina Chrysohoou

- Christos Pitsavos

- Demosthenes Panagiotakos

- Petros P. Sfikakis

- Evrydiki Kravvariti

13. Association of apolipoprotein B, excess apolipoprotein B and apoB/apoA1 ratio with 20-year atherosclerotic cardiovascular disease risk: the ATTICA study (2002–2022)

- Sofia-Panagiota Giannakopoulou

- Christina Chrysohoou

- Smaragdi Antonopoulou

- Fotios Barkas

- Evangelos Liberopoulos

- Petros P. Sfikakis

- Christos Pitsavos

- Costas Tsioufis

- Demosthenes Panagiotakos